Clinical Trials in San Antonio

Showing 11341-11360 of 12,572 trials

S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma

NCT00080847

This randomized phase II trial is studying rituximab and combination chemotherapy to see how well they work compared to oblimersen, rituximab, and combination chemotherapy in treating patients with advanced diffuse large B-cell non-Hodgkin's lymphoma. Monoclonal antibodies, such as rituximab, can locate cancer cells and either kill them or deliver cancer-killing substances to them without harming normal cells. Drugs used in chemotherapy, such as cyclophosphamide, doxorubicin, vincristine, and prednisone, work in different ways to stop cancer cells from dividing so they stop growing or die. Oblimersen may increase the effectiveness of anticancer drugs by making cancer cells more sensitive to the drugs. Combining rituximab and combination chemotherapy with oblimersen may kill more cancer cells

Contiguous Stage II Adult Diffuse Large Cell LymphomaNoncontiguous Stage II Adult Diffuse Large Cell LymphomaStage III Adult Diffuse Large Cell Lymphoma+1 more

National Cancer Institute (NCI)160 participantsStarted Mar 2004

San Antonio, Texas, United States

COMPLETEDPhase 3< 1 mile

Iressa Expanded Access Program (EAP)

NCT00034879

A program for patients with non small cell lung cancer who may benefit from Iressa, but cannot enter another clinical trial due to them not being eligible, or for whom no trials are available.

CarcinomaNon-small-cell LungMetastases+1 more

AstraZenecaStarted Aug 2000

Alabaster, Alabama, United States • Anniston, Alabama, United States • Birmingham, Alabama, United States +623 more locations

S0349 Rituximab, Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone With or Without Oblimersen in Treating Patients With Advanced Diffuse Large B-Cell Non-Hodgkin's Lymphoma

Iressa Expanded Access Program (EAP)

Find Trials by Condition in San Antonio

Quetiapine Fumarate (SEROQUEL) Compared to Placebo in the Treatment of Children & Adolescents With Bipolar I Mania

CAFE Comparison of Atypicals in First Episode of Psychosis

A Study in Erectile Dysfunction

Vascular Endothelial Growth Factor VEGF Trap-Eye:Investigation of Efficacy and Safety in Wet Age-Related Macular Degeneration(AMD)

Effectiveness of Pacemaker With Closed Loop Stimulation Compared to Pacemakers With and Without Standard Rate Response

Controlled Study of the Use of Quetiapine Fumarate in the Treatment of Patients With Bipolar Depression

Seroquel in Bipolar Depression Versus SSRI

A Dose-finding Phase IIb Study With AZD0865 and Esomeprazole in GERD Patients With Erosive Esophagitis.

Immediate Release (IR) to Sustained Release (SR) Switching Study: Study of Switching From IR Seroquel to SR Seroquel in Outpatients With Schizophrenia

S9912 Combination Chemo in Stage III Ovarian Cancer,

Study of Antidepressants in Parkinson's Disease

Safety of NXY-059 for the Treatment of Patients Who Have Suffered From a Stroke

Study of ABT-869 in Subjects With Advanced Renal Cell Carcinoma Who Have Previously Received Treatment With Sunitinib

A Phase 2 Trial of Standard Chemotherapy, With or Without BSI-201, in Patients With Triple Negative Metastatic Breast Cancer

An Open Label Extension Study of STX209 in Subjects With Fragile X Syndrome

An Open Label Extension Study of STX209 in Subjects With Autism Spectrum Disorders

S0511, Goserelin and Anastrozole in Treating Men With Recurrent or Metastatic Breast Cancer

Phase 2 Study of ABT-869 in Advanced Hepatocellular Carcinoma (HCC)